Zura Bio Limited Class A Ordinary Shares (ZURA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $104.03M
Last updated: Nov 17, 2026 at 4:26 PM ET
Zura Bio Limited Class A Ordinary Shares (ZURA) Statistics
Zura Bio Limited Class A Ordinary Shares (ZURA) has a market cap of $104.03M. Its share count is up 35.05% from a year earlier. It holds $187.65M more cash than debt, 180.38% of its market cap.
Total Valuation
| Market Cap | $104.03M |
|---|---|
| Latest price (Nov 17, 2026) | $1.03 |
Key Dates
The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 27, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 74.63% over 52 weeks and trades 72.97% below its 50-day average.
| Beta (1Y) | 0.07 |
|---|---|
| 52-Week Change | -74.63% |
| 1-Month Change | -72.83% |
| 3-Month Change | -82.28% |
| 6-Month Change | -74.06% |
| 5-Year Change | -59.07% |
| Total Return (1Y) | -74.63% |
| Total Return (3Y CAGR) | -37.45% |
| Total Return (5Y CAGR) | -36.36% |
| Return vs SPY (1Y) | -84.54% |
| Max Drawdown (1Y) | -85.30% |
| Max Drawdown (3Y) | -85.30% |
| Sharpe Ratio (1Y) | -0.90 |
| Correlation with SPY (1Y) | 0.01 |
| 50-Day Average | $3.81 |
| 200-Day Average | $5.03 |
| 52-Week Range | $0.93 to $7.44 |
| RSI (14 Days) | 24.9 |
| Average Volume (20 Days) | 7.80M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 11.29x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 11.29x |
|---|---|
| Quick Ratio | 11.29x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -52.64% and return on assets is -48.05% over the last 12 months.
| Return on Equity (ROE) | -52.64% |
|---|---|
| Return on Assets (ROA) | -48.05% |
| ROA (5Y Average) | -15.17% |
Scores
ZURA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue of $0 over the last 12 months is down 100.00% from the 12 months before.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$15.00K |
| Operating Income | -$102.00M |
| Pretax Income | -$94.83M |
| Net Income | -$93.53M |
| Reported EPS (TTM) | -$1.12 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 91.28% of the $194.63M in total assets.
| Cash and Equivalents | $187.65M |
|---|---|
| Total Debt | $0 |
| Net Cash | $187.65M |
| Net Cash Per Share | $1.47 |
| Working Capital | $174.62M |
| Shareholder Equity | $177.66M |
| Book Value Per Share | $1.39 |
| Total Assets | $194.63M |
| Total Liabilities | $16.97M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $43.00K of capital spending, operating cash flow left -$22.38M of free cash flow.
| Operating Cash Flow | -$22.34M |
|---|---|
| Capital Expenditures | $43.00K |
| Free Cash Flow | -$22.38M |
| FCF Per Share | -$0.23 |
| Depreciation and Amortization | $46.99K |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -7.53% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -7.53% |
Dividends and Yields
ZURA does not pay a dividend. Its free cash flow yield is -16.93%.
| FCF Yield | -16.93% |
|---|---|
| Buyback Yield | -0.10% |
| Shareholder Yield | -0.10% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About ZURA
What is ZURA's market cap?
Zura Bio Limited Class A Ordinary Shares has a market cap of $104.03M.
How many shares of ZURA are outstanding?
Zura Bio Limited Class A Ordinary Shares has 127.71M shares outstanding. The count is up 35.05% from a year earlier.
Does ZURA pay a dividend?
No. Zura Bio Limited Class A Ordinary Shares does not pay a dividend.
How much debt does ZURA have?
Zura Bio Limited Class A Ordinary Shares has $0 of total debt and $187.65M of cash and equivalents, a net cash position of $187.65M.
ZURA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors